Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Microsoft Corporation (Symbol: MSFT), where a total of 246,494 contracts have traded so far, representing approximately 24.6 million underlying shares. That amounts to about 109.1% of MSFT's average daily trading volume over the past month of 22.6 million shares. Particularly high volume was seen for the $245 strike call option expiring September 16, 2022, with 28,199 contracts trading so far today, representing approximately 2.8 million underlying shares of MSFT. Below is a chart showing MSFT's trailing twelve month trading history, with the $245 strike highlighted in orange:
Johnson & Johnson (Symbol: JNJ) options are showing a volume of 67,564 contracts thus far today. That number of contracts represents approximately 6.8 million underlying shares, working out to a sizeable 102.4% of JNJ's average daily trading volume over the past month, of 6.6 million shares. Particularly high volume was seen for the $167.50 strike call option expiring September 16, 2022, with 31,600 contracts trading so far today, representing approximately 3.2 million underlying shares of JNJ. Below is a chart showing JNJ's trailing twelve month trading history, with the $167.50 strike highlighted in orange:
And Moderna Inc (Symbol: MRNA) options are showing a volume of 34,333 contracts thus far today. That number of contracts represents approximately 3.4 million underlying shares, working out to a sizeable 73.9% of MRNA's average daily trading volume over the past month, of 4.6 million shares. Particularly high volume was seen for the $140 strike call option expiring September 16, 2022, with 5,747 contracts trading so far today, representing approximately 574,700 underlying shares of MRNA. Below is a chart showing MRNA's trailing twelve month trading history, with the $140 strike highlighted in orange:
For the various different available expirations for MSFT options, JNJ options, or MRNA options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
